Clinically relevant concentration of sevoflurane suppresses cervical cancer growth and migration through targeting...

Area of Science:

• Oncology
• Anesthesiology
• Molecular Biology

Background:

• The effects of volatile anesthetics like sevoflurane on cancer cells are debated, with conflicting reports on tumor promotion versus anti-cancer activity.
• Understanding sevoflurane's precise biological impact on cancer is crucial for clinical applications.

Purpose of the Study:

• To investigate the effects of clinically relevant sevoflurane doses on cervical cancer cell biology.
• To elucidate the underlying molecular mechanisms of sevoflurane's action in cervical cancer.

Main Methods:

• Utilized a panel of cervical cancer cell lines to assess sevoflurane's impact on proliferation, migration, and survival.
• Analyzed downstream signaling pathways, including Ras/Erk/Akt and Rho/MYPT1/MLC, by measuring GTPase activities.
• Conducted rescue studies using Rho activator and constitutively active Ras to validate molecular targets.

Main Results:

• Sevoflurane significantly inhibited proliferation and migration of cervical cancer cells.
• Sevoflurane did not impact cervical cancer cell survival but enhanced chemosensitivity.
• Sevoflurane suppressed Ras and RhoA GTPase activities, with distinct pathways mediating anti-proliferative and anti-migratory effects.

Conclusions:

• Sevoflurane exhibits significant anti-cancer effects in cervical cancer cells, primarily by inhibiting proliferation and migration.
• The anti-proliferative effect is linked to Ras inhibition, while anti-migration is mediated by RhoA inhibition.
• These findings offer preclinical insights into sevoflurane's potential role in managing cervical cancer growth and metastasis.